|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Deferred income taxes | |||||
| Unrealized (gain) loss on equity investments | |||||
| Impairment charges for facilities consolidation | |||||
| Restructuring charges | |||||
| Data center assets abandonment | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Partners payable | |||||
| Accrued expenses and other current liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Proceeds relating to property and equipment | |||||
| Purchases of marketable securities | |||||
| Sales and maturities of marketable securities | |||||
| Payments for held-for-sale assets | |||||
| Proceeds from Venture distribution | |||||
| Purchases of non-marketable equity investments | |||||
| Acquisitions of businesses and intangible assets | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Repurchases of Class A common stock | |||||
| Payments for dividends and dividend equivalents | |||||
| Proceeds from issuance of long-term debt, net | |||||
| Principal payments on finance leases | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash equivalents | |||||
| Cash, cash equivalents, and restricted cash equivalents at beginning of the period | |||||
| Cash, cash equivalents, and restricted cash equivalents at end of the period | |||||
| Supplemental cash flow data | |||||
| Cash paid for income taxes, net | |||||
| Cash paid for interest, net of amounts capitalized | |||||
| Non-cash investing and financing activities: | |||||
| Property and equipment in accounts payable and accrued expenses and other current liabilities | |||||
| Other current assets through financing arrangement in accrued expenses and other current liabilities | |||||
| Acquisition of businesses and intangible assets in accounts payable, accrued expenses and other current liabilities, and other liabilities | |||||
| Repurchases of Class A common stock in accrued expenses and other current liabilities | |||||
| Reconciliation of cash, cash equivalents, and restricted cash equivalents to the consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash and cash equivalents | |||||
| Restricted cash, included in prepaid expenses and other current assets | |||||
| Restricted cash, included in other assets | |||||
| Total restricted cash and cash equivalents | |||||
| Restricted cash equivalents, included in prepaid expenses and other current assets | |||||
| Restricted cash equivalents, included in other assets | |||||
Loading...